Miracle Mile Advisors’s Verrica Pharmaceuticals VRCA Stock Holding History

Miracle Mile Advisors’s Portfolio VRCA Stock Details VRCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5,977	Closed	-$31.7K	–	851
2025 Q2	$31.7K	Sell	5,977 -2,423	-29%	-$13K	﹤0.01%	713
2025 Q1	$37.1K	Hold	8,400	–	–	﹤0.01%	638
2024 Q4	$58.8K	Hold	8,400	–	–	﹤0.01%	626
2024 Q3	$122K	Hold	8,400	–	–	﹤0.01%	507
2024 Q2	$612K	Sell	8,400 -3,422	-29%	-$263K	0.01%	325
2024 Q1	$700K	Hold	11,822	–	–	0.02%	310
2023 Q4	$865K	Hold	11,822	–	–	0.02%	280
2023 Q3	$459K	Hold	11,822	–	–	0.01%	336
2023 Q2	$682K	Hold	11,822	–	–	0.02%	305
2023 Q1	$768K	Sell	11,822 -678	-5%	-$41K	0.02%	311
2022 Q4	$344K	Hold	12,500	–	–	0.01%	408
2022 Q3	$365K	Hold	12,500	–	–	0.02%	332
2022 Q2	$240K	Buy	+12,500	New	+$628K	0.01%	390

Other funds holding VRCA

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sovran Advisors San Diego, California $1.34B AUM 21.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

Miracle Mile Advisors's VRCA Position: Q3 2025 in Review

Miracle Mile Advisors sold out of Verrica Pharmaceuticals (VRCA) in Q3 2025, closing a stake of 5,977 shares — an estimated $31.7K sold.

Miracle Mile Advisors first reported a position in VRCA in Q2 2022 and held it in 13 quarters. The position peaked at $865K in Q4 2023. 34 funds tracked by Wall St. Rank hold VRCA as of Q3 2025.

Miracle Mile Advisors reported no remaining Verrica Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
Miracle Mile Advisors sold 5,977 Verrica Pharmaceuticals shares in Q3 2025, an estimated $31.7K.
Miracle Mile Advisors first reported a position in Verrica Pharmaceuticals in Q2 2022 and held it in 13 quarters.
Miracle Mile Advisors's Verrica Pharmaceuticals position peaked at $865K in Q4 2023.
34 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q3 2025.

Based on Miracle Mile Advisors's 13F filing for Q3 2025, filed 20 Oct 2025.